Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Imiquimod cream can rarely cause temporary hair loss.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Widened sweat ducts are a very specific sign of scarring hair loss.